Saturday, July 11, 2026

pharma · Acne Vulgaris

Cutia Therapeutics (Shanghai)

Cutia Therapeutics (Shanghai) drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Drug Pipeline

Cutia Therapeutics (Shanghai) pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Cutia Therapeutics (Shanghai) drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to Cutia Therapeutics (Shanghai) in public FDA and regional records.